Related Experiment Video

Updated: Jul 13, 2026

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
10:51

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists

Published on: November 15, 2013

The non-genomic crosstalk between PPAR-gamma ligands and ERK1/2 in cancer cell lines

Efstathia Papageorgiou1, Nea Pitulis, Pavlos Msaouel

  • 1National & Kapodistrian University of Athens, Department of Experimental Physiology, Medical School, Goudi-Athens, Greece.

Expert Opinion on Therapeutic Targets
|August 2, 2007
PubMed

Insights

Peroxisome proliferator activated receptors (PPARs), particularly PPAR-gamma, influence cancer through genomic and non-genomic pathways. Ligands activate ERK1/2, impacting cancer cell behavior and potentially offering new anticancer therapies.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Peroxisome proliferator activated receptors (PPARs) are nuclear receptors regulating gene expression.
  • PPAR-gamma is expressed in various cells and influences cancer biology through genomic and non-genomic mechanisms.
  • Non-genomic actions involve signaling pathways like MAPK, with rapid ERK1/2 phosphorylation observed.

Purpose of the Study:

  • To review the interplay between PPAR-gamma ligands and activated ERK1/2.
  • To explore their combined role in antineoplastic actions within cancer cell lines.
  • To assess the potential for improved anticancer therapies.

Main Methods:

  • Literature review focusing on PPAR-gamma, ERK1/2 signaling, and cancer cell lines.
  • Analysis of studies investigating genomic and non-genomic effects of PPAR-gamma ligands.
  • Examination of research on ERK1/2 phosphorylation and its consequences.

Main Results:

  • PPAR-gamma ligands induce rapid ERK1/2 phosphorylation in cancer cells.
  • Activated ERK1/2 mediates non-genomic cellular effects.
  • ERK1/2 can phosphorylate and repress PPAR-gamma transcriptional activity.

Conclusions:

  • The interrelation between PPAR-gamma ligands and activated ERK1/2 is crucial for antineoplastic effects.
  • Understanding these non-genomic interactions may lead to novel anticancer strategies.
  • Targeting this pathway holds promise for developing improved cancer treatments.

More Related Videos

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells10:13

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells

Published on: July 3, 2013

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...